After having identified the barriers hindering European level competitiveness in the field of molecular medicine for Hungary, the University of Debrecen, the University of Szeged, the Semmelweis University and the Biological Research Center of the Hungarian Academy of Sciences united to create the Hungarian Centre of Excellence for Molecular Medicine (HCEMM). They were joined by the National Research, Innovation and Development Office representing the Hungarian Government as project coordinator and by the European Molecular Biology Laboratory as leading scientific institution.
The goal of creating HCEMM is to develop a “game changer” organization in the form of a non-profit Ltd. which catalyzes reforming changes in the research culture and makes impact in the regional development of three Hungarian “knowledge regions”. The organizational and management model will ensure autonomy and scientific excellence with an international evaluation system. Research groups will be pursuing in cross cutting fields and will be reviewed every 5 years in order to ensure scientific excellence. Advanced core facilities, effective technology transfer and vibrant links to industry will also be provided. The headquarters will be in Szeged and the research groups will be located in state of the art facilities in Szeged and in Budapest. EMBL and HCEMM Nonprofit Kft. will conclude a partnership agreement, ensuring a continuous transfer of institutional, research and collaborative expertise, and access to the EMBL partnership network in Europe and beyond.
Financing stability of HCEMM will be based on 52 M € coming from H2020 Teaming, the Hungarian Government and the founding institutions. For the long term sustainability the Governmental commitment and the financial support of the founding institutions will be gradually supplemented by increasing streams of income from diverse grant schemes, technology transfer, services, industrial collaborations.
Call for proposal
See other projects for this call